Cheaper protein shakes are crushing this industry stalwart

BellRing Brands shares fell more than 42% after higher costs and competitive price cuts pressured quarterly results and outlook. The company also reported the first slowdown in purchasing trends in several years, raising concerns that the protein boom is losing momentum. The move is likely to hit BRBR specifically rather than the broader market.

Analysis

The market is treating this as a single-name execution miss, but the bigger signal is that premium protein has moved from scarcity economics to a price-elastic category. Once private label and low-cost challenger brands demonstrate acceptable taste and mixability, branded incumbents lose the ability to lean on household penetration and must spend more to defend shelf space, which compresses both gross margin and retailer economics. That creates a second-order risk for adjacent premium snack and functional-food names: if retailers see category volume can be preserved at lower ASPs, they will push price concessions across the aisle, not just at BRBR.

The key issue is timing. In the next 1-2 quarters, the earnings reset is likely to be more severe than the revenue reset because promotions tend to hit mix before they show up fully in unit growth. If management responds by cutting trade spend, the brand can lose velocity faster than expected; if they defend share aggressively, margin erosion can persist into the next fiscal year. Either path raises the probability of multiple compression across the broader branded nutrition complex, especially for names priced as durable growth franchises.

The contrarian view is that the move may be overshooting near-term because the stock is now discounting a permanent category collapse rather than a normalization from unusually strong sell-through. If protein remains a secular behavior rather than a fad, volume can re-accelerate once pricing stabilizes and the comparison base resets. But that would require evidence that consumers are choosing protein on need-state rather than brand, and that the incumbent can re-assert differentiation without chasing price down the shelf.

Key Decisions for Investors

• Short BRBR on any post-gap bounce over the next 3-5 trading sessions; use a 4-6 week horizon and treat prior support as resistance. Risk/reward favors sellers if management has to reset guidance again before the next print.
• Pair trade: long lower-cost protein/private-label supply chain beneficiaries versus short branded premium nutrition names over 1-3 months. The setup is for margin migration away from brands that need promotion to defend velocity.
• Buy short-dated BRBR puts or put spreads into any stabilization attempt, targeting the next earnings-related catalyst. Best payoff comes if the market keeps applying multiple compression before fundamentals fully bottom.
• Avoid initiating fresh longs in adjacent premium consumer health/fitness food names until there is evidence that category pricing has stabilized for at least one reporting cycle. The risk is contagion through retailer negotiations and promotion intensity.
• For event-driven accounts, consider a tactical long-volatility structure on BRBR over the next 30-45 days. The name now has asymmetric downside if guidance cuts continue, but the move is large enough that a squeeze on any reassuring commentary could be tradable.